NCT00815659 - Effect of Crestor (Rosuvastatin) on Lipid Levels in Patients With Metabolic Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions

Metabolic Syndrome

Interventions

DRUG

rosuvastatin

medication start dose is 10mg. After 6 weeks of treatment will be force-titrated to 20mg.

Trial Locations (6)

Research site, Ankara

Research site, Kayseri

Research site, Istanbul

Research site, Kocaeli

Research Site, Izmir

Research Site, Trabzon